---
title: "Swiss Biotech Day – Basel"
id: "1821"
type: "post"
slug: "swiss-biotech-day-basel"
published_at: "2026-04-20T09:56:42+00:00"
modified_at: "2026-05-26T10:58:44+00:00"
url: "https://innocorepharma.com/news-events/swiss-biotech-day-basel/"
markdown_url: "https://innocorepharma.com/news-events/swiss-biotech-day-basel.md"
taxonomy_category:
  - "Events"
---

Basel - 4 & 5 May 2026

# Swiss Biotech Day – Basel

# **InnoCore Pharmaceuticals to Join Swiss Biotech Day 2026 in Basel**

InnoCore Pharmaceuticals is excited to announce its participation in [Swiss Biotech Day 2026](https://swissbiotechday.ch/)
, one of Europe’s leading biotechnology conferences, taking place on May 4 & 5, 2026, at the Congress Center Basel. The event brings together more than 3,000 senior life sciences experts, over 130 exhibitors, and 25 international delegations, making it one of the most impactful networking and innovation hubs in the global biotech ecosystem.

## **Why This Event Matters for InnoCore**

Participating in Swiss Biotech Day supports InnoCore’s mission to accelerate the development of long‑acting therapeutics through strong scientific partnerships. By engaging with key stakeholders—including biotech firms, pharma innovators, translational research centers, and investors—we aim to:

- Expand collaborations in polymer‑based drug delivery
- Explore new formulation and licensing partnerships
- Share insights on controlled‑release technologies
- Strengthen our global network within the biotech ecosystem

Swiss Biotech Day’s focus on innovation aligns perfectly with InnoCore’s commitment to delivering reliable, effective, and customizable long‑acting injectable solutions.

## **Join Us in Basel**

We invite partners, collaborators, and industry professionals to meet [Vincent](https://innocorepharma.com/company/people/vincent-de-boer/)
 and [Martin](https://innocorepharma.com/company/people/martin-bakker/)
 during the event. Whether you’re exploring new delivery technologies, seeking R&D collaboration, or scouting for innovative biotech capabilities, InnoCore Pharmaceuticals is ready to connect.Reach out through the form below, or meet us in person

"*" indicates required fields

Related insights

[26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/)
[11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/)
[01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)